TENX
NASDAQ · Biotechnology
Tenax Therapeutics Inc
$1.87
+0.04 (+2.19%)
Open$1.81
Previous Close$1.83
Day High$1.87
Day Low$1.71
52W High$19.40
52W Low$5.78
Volume—
Avg Volume1.75M
Market Cap495.87M
P/E Ratio—
EPS$-1.40
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+1,682.4% upside
Current
$1.87
$1.87
Target
$33.33
$33.33
$30.09
$33.33 avg
$42.13
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 19.99M | 20.76M | 15.61M |
| Net Income | 4.98M | 4.98M | 3.68M |
| Profit Margin | 24.9% | 24.0% | 23.6% |
| EBITDA | 7.23M | 8.32M | 5.37M |
| Free Cash Flow | 5.95M | 3.82M | 3.47M |
| Rev Growth | +24.3% | +21.0% | +20.1% |
| Debt/Equity | 0.81 | 0.72 | 0.85 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 35.2 | 28.41B |